GH
PACB icon

GAM Holding’s Pacific Biosciences PACB Stock Holding History

GAM Holding’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,659
Closed -$464K – 323
2021
Q4 		$464K Sell
22,659
-7,011
-24% -$169K 0.02% 241
2021
Q3 		$758K Hold
29,670
– – 0.04% 214
2021
Q2 		$1.04M Buy
+29,670
New +$863K 0.05% 222
2019
Q2 		– Sell
-126,500
Closed -$915K – 916
2019
Q1 		$915K Sell
126,500
-46,000
-27% -$333K 0.04% 455
2018
Q4 		$1.28M Buy
+172,500
New +$1.09M 0.06% 305

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

GAM Holding's PACB Position: Q1 2022 in Review

GAM Holding sold out of Pacific Biosciences (PACB) in Q1 2022, closing a stake of 22,659 shares — an estimated $464K sold.

GAM Holding first reported a position in PACB in Q4 2018 and held it in 5 quarters. The position peaked at $1.28M in Q4 2018. 249 funds tracked by Wall St. Rank hold PACB as of Q1 2022.

  • GAM Holding reported no remaining Pacific Biosciences position as of Q1 2022 after selling out during the quarter.
  • GAM Holding sold 22,659 Pacific Biosciences shares in Q1 2022, an estimated $464K.
  • GAM Holding first reported a position in Pacific Biosciences in Q4 2018 and held it in 5 quarters.
  • GAM Holding's Pacific Biosciences position peaked at $1.28M in Q4 2018.
  • 249 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2022.

Based on GAM Holding's 13F filing for Q1 2022, filed 6 May 2022.